Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 1295
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00458549 | Polyunsaturated Fatty Acids in Treating Patients With Prostate Cancer Undergoing Prostate Biopsy and/or Surgery | ||
| NCT02658279 | Pembrolizumab (MK-3475) in Patients With Recurrent Malignant Glioma With a Hypermutator Phenotype | ||
| NCT05759143 | Enhancing Information Management for Young Adults After Genetic Cancer Risk Testing | ||
| NCT01829217 | Sunitinib in Never-Smokers With Lung Adenocarcinoma | ||
| NCT00405782 | Exercise Intervention in Women With Metastatic Breast Cancer | ||
| NCT05423730 | Alcohol and Breast Cancer (ABC) Trial | ||
| NCT04160065 | Immunotherapy With IFx-Hu2.0 Vaccine for Advanced Non-melanoma Skin Cancers | ||
| NCT04620187 | Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas | ||
| NCT01085201 | Adenosine 2A Agonist Lexiscan in Children and Adults With Sickle Cell Disease | ||
| NCT01188876 | Carboplatin/Pralatrexate in Recurrent Platinum-Sensitive Ovarian, Fallopian or Primary Peritoneal Cancer | ||
| NCT04947917 | Axillary Lymph Node Tattoo Marking Study | ||
| NCT00903162 | Extended Endocrine Therapy for Premenopausal Women With Breast Cancer | ||
| NCT00004163 | Trastuzumab in Treating Patients With Advanced Salivary Gland Cancer | ||
| NCT00670982 | Bevacizumab in Combination With Vinorelbine and Trastuzumab for HER2-Positive, Metastatic Breast Cancer | ||
| NCT00114985 | Prostate Immobilization Device Used During Radiation Treatments to Decrease Rectal Bleeding | ||
| NCT01024946 | Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity | ||
| NCT02282735 | Parental Decision-Making for Children With Relapsed Neuroblastoma | ||
| NCT01753089 | Dendritic Cell Activating Scaffold in Melanoma | ||
| NCT00997334 | Erlotinib Therapy and Subsequent Development of Mechanisms of Secondary Resistance in Patients With NSCLC | ||
| NCT04855695 | Avo In R/R And Previously Untreated MCL | ||
| NCT04895436 | Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL) | ||
| NCT00458237 | Dose Escalation Followed by Study of RAD001 in Combination With Trastuzumab in HER2-Positive Metastatic Breast Cancer | ||
| NCT06463457 | Comeback From Long coursE Androgen Deprivation Therapy (ADT) With RElugolix and Darolutamide (CLEARED) | ||
| NCT05632328 | AGEN1423 and Botensilimab w/ or w/o Chemo in PDAC | ||
| NCT06084234 | National Liver Cancer Screening Trial | ||
| NCT00361309 | SU011248 in Advanced Hepatocellular Carcinoma | ||
| NCT02384239 | A Study of Palbociclib in Combination With Fulvestrant or Tamoxifen as Treatment for Metastatic Breast Cancer | ||
| NCT04906200 | Web-Based Symptom Monitoring and Self-Management Portal (YES) for Adolescent and Young Adult Breast Cancer Survivors | ||
| NCT00181701 | Intraperitoneal Paclitaxel and Carboplatin in the Treatment of Women With Carcinoma of Mullerian Origin | ||
| NCT00385853 | PTK787/ZK 222584 in Combination With Temozolomide and Radiation in Patients With Glioblastoma Taking Enzyme-Inducing Anti-Epileptic Drugs | ||
| NCT04368130 | SIGNAL:Identifying Behavioral Anomalies Using Smartphones to Improve Cancer Care | ||
| NCT05419479 | Switch Maintenance in Pancreatic | ||
| NCT01472627 | Effects of Bortezomib-Based Therapy on Cellular Immunity and Response to DC/Myeloma Fusion Vaccines in Vitro | ||
| NCT02279394 | E-PRISM: Phase II Trial of Elotuzumab Lenalidomide and Dexamethasone in High-Risk Smoldering Multiple Myeloma | ||
| NCT03101254 | LY3022855 With BRAF/MEK Inhibition in Patients With Melanoma | ||
| NCT02689401 | MRI Iron Oxide Imaging for Lymph Node Staging in Esophageal Cancer | ||
| NCT01543620 | Prospective Observational Study to Evaluate Biomarkers of Aminoglycoside Nephrotoxicity in Patients With Cystic Fibrosis | ||
| NCT03469258 | Study of Pancreatic Enzyme Replacement on Completion of Adjuvant Chemotherapy for Resected Pancreatic Adenocarcinoma | ||
| NCT06950307 | Hypofractionation for Prostate Cancer in Africa: A Feasibility Study | ||
| NCT00095901 | Capecitabine For Nasopharyngeal Cancer | ||
| NCT01858688 | A Phase II, Prospective Study of MRI in the Reclassification of Men Considering Active Surveillance in Prostate Cancer | ||
| NCT01288235 | Proton Radiotherapy for Pediatric Brain Tumors Requiring Partial Brain Irradiation | ||
| NCT00392665 | Bevacizumab/Tarceva and Tarceva/Sulindac in Squamous Cell Carcinoma of the Head and Neck | ||
| NCT00047281 | Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant Glioma | ||
| NCT00357500 | Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer | ||
| NCT02641236 | Gut Decontamination In Pediatric Allogeneic Hematopoietic | ||
| NCT01185509 | Trastuzumab and Vinorelbine in Advanced Breast Cancer | ||
| NCT05057247 | Duvelisib Plus Docetaxel In Recurrent/Metastatic HNSCC | ||
| NCT03595917 | ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML | ||
| NCT00020618 | Inhaled Morphine Compared With Morphine By Mouth in Treating Cancer Patients With Breakthrough Pain |
